Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Immunovant Inc

IMVT
Current price
39.19 USD -0.44 USD (-1.11%)
Last closed 39.02 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 5 866 043 904 USD
Yield for 12 month +170.65 %
Week
Month
Year
IMVT
21.11.2021 - 28.11.2021

Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that target the neonatal fragment crystallizable receptor for the treatment of myasthenia gravis, thyroid eye disease, chronic inflammatory demyelinating polyneuropathy, and Graves diseases, as well as warm autoimmune hemolytic anemia. The company is headquartered in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd. Address: 320 West 37th Street, New York, NY, United States, 10018

Analytics

WallStreet Target Price

49.42 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures IMVT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -245 852 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -42.71 %
PEG Ratio
Return On Equity TTM -78.84 %
Wall Street Target Price 49.42 USD
Revenue TTM
Book Value 1.92 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings Share -1.96 USD
Diluted Eps TTM -1.96 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics IMVT

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History IMVT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation IMVT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -22.7646
Price Book MRQ 23.2954

Financials IMVT

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators IMVT

For 52 weeks

14.05 USD 44.19 USD
50 Day MA 34.67 USD
Shares Short Prior Month 6 685 190
200 Day MA 23.13 USD
Short Ratio 5.49
Shares Short 7 062 012
Short Percent 10.19 %